AHR and cancer: However, immunosuppression caused by activation of the KYN-AHR pathway is accompanied by different mechanisms that arrest the production of effector T cells, promote IL10 production (potent anti-inflammatory cytokine), and enhance the proliferation of Treg cells, which support immune escape from cancer cells [109].